Biohaven Ltd.

US$14.48As of Sun 8 Nov 2026, 12:00 UTC
NYSE:BHVNHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR 22.46%
Div yield —
ROE —
Biotechnology
Beta (5Y) 3.13
PE TTM —
TSR TTM (15.81%)
Mkt cap US$2.187B
ROIC (122.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
28.30%
(90.77%)
Hold 9|6|8|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.17
0.18
0.19
16.95%
14.63%
15.47%
20.48%
Revenue$M
98.02
99.96
100.9
102.6
5.01%
5.56%
4.97%
9.01%
Peers (US$2.187B)
Cap (US$)
PE
2.208B
—
Capital
TTM
5Y
10Y
Leveragex
1.048
(0.258)
(0.234)
EBIT/Intx
0.625
0.160
0.159
Own earn%
(51.78)
(71.56)
(72.11)
Sh yield%
31.06
36.61
36.59
Owners
Insiders/Inst%
14.56
48.88
Short interest%
3.75
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
17–23
$1 testx
0.0
Incr. ROIC%
1